The company focuses on the regenerative potential of amnion and other placental tissues, utilizing their unique biological structure, rich source of undifferentiated stem cells, and immune privilege. BioD is committed to advancing regenerative medicine and reducing healthcare costs by developing innovative solutions. They have a robust development pipeline with over 25 patent applications filed for their proprietary processing techniques and clinical use of their products. BioD's products are designed to improve clinical outcomes while maintaining unsurpassed safety and quality standards.